– USA, CA – Natus Medical Incorporated (NASDAQ: NTUS), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced the appointment of Ilan Daskal, current CFO & Executive Vice President of Bio-RAD Laboratories, to its board of directors and audit committee effective March 19, 2020. The Company will also nominate Mr. Daskal at its 2020 Annual Meeting of Stockholders.
“We are pleased to welcome Ilan as a new independent director to the Natus board,” said Barbara R. Paul, M.D., Chairperson. “Ilan’s extensive financial and operational experience complement our current board members, strengthening the board and company as we focus on driving value for our customers, employees and stockholders.”
Natus’ other directors consist of Barbara R. Paul, M.D., former Chief Medical Officer of Community Health Systems, Joshua Levine, President and CEO of Accuray, Incorporated, Kenneth Ludlum, former CFO of CareDx, Inc., Lisa Wipperman Heine, President & CEO of PreCardia, Inc., Alice D. Schroeder, former CEO and Chair of WebTuner Corporation, Thomas J. Sullivan, President and CEO of A&E Medical Corporation, and Jonathan Kennedy, President and CEO of the Company.
Kenneth Ludlum has advised the board that he will not stand for re-election at the 2020 Annual Meeting of Stockholders. Mr. Ludlum has served on the Natus board of directors and as Chairman of the Audit Committee since 2002. We thank him for his service and the contributions he has made to the success and growth of the Company over his 18-year tenure. Following Mr. Ludlum’s retirement, the Natus board will be composed of seven directors.
About Ilan Daskal
Currently, Ilan Daskal holds the position of Executive Vice President and Chief Financial Officer of Bio-Rad Laboratories, Inc.
Over his career, Mr. Daskal has held numerous senior financial roles and CFO positions at both public and private companies that include Lumileds, International Rectifier Corporation and Infineon. Mr. Daskal also served on the Board of Directors of Ixia.
Mr. Daskal holds a Masters in Finance degree from the City University of New York and a BB in Accounting from Tel-Aviv College of Business in Israel.
About Natus Medical Incorporated
Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
For more information: https://natus.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.